Dr Danielle Vance obtained a BSci (Hons) in Medicinal Chemistry and a PhD in Organic Chemistry from Queen’s University Belfast. Danielle joined Randox in 2011 as a Research Scientist working on the development of clinical immunoassays for the Evidence platforms. Danielle manages a team of scientists within the R&D Clinical immunoassay development department who are responsible for the development of new clinical multiplexed assays for improved sensitivity and detection of cardiac targets (Troponin I, H-FABP and CKMB), thyroid targets (FT3, FT4, TSH, TT3, TT4), and other clinically relevant arrays such as the Endocrine array, Anaemia array and the Metabolic Syndrome array.
Scientific Shorts